Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma

The early detection of papillary thyroid cancer has contributed to the increase in the incidence and improved clinical outcomes. However, recent changes of medullary thyroid carcinoma (MTC) over time remain unclear. We evaluated changes of the clinicopathological characteristics and clinical outcomes in patients with MTC in recent years.

[1]  Jeong Hyun Lee,et al.  Recent Changes in the Clinical Outcome of Papillary Thyroid Carcinoma With Cervical Lymph Node Metastasis. , 2015, The Journal of clinical endocrinology and metabolism.

[2]  Douglas B. Evans,et al.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.

[3]  Tae Yong Kim,et al.  A cut‐off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma , 2015, Clinical endocrinology.

[4]  W. Kim.  A Closer Look at Papillary Thyroid Carcinoma , 2015, Endocrinology and metabolism.

[5]  Tae Yong Kim,et al.  Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010 , 2014, Endocrinology and metabolism.

[6]  Hyeong Sik Ahn,et al.  Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. , 2014, The New England journal of medicine.

[7]  Tae Yong Kim,et al.  Time Trends Analysis of Characteristics of Patients with Thyroid Cancer in a Single Medical Center , 2014 .

[8]  Tae Yong Kim,et al.  Current Status and Future Perspectives in Differentiated Thyroid Cancer , 2014, Endocrinology and metabolism.

[9]  T. Samulski,et al.  The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience. , 2014, Pathology, research and practice.

[10]  M. Banerjee,et al.  The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer. , 2014, The Journal of clinical endocrinology and metabolism.

[11]  Y. Youn,et al.  Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. , 2013, Thyroid : official journal of the American Thyroid Association.

[12]  P. Levine,et al.  Detection of medullary thyroid microcarcinoma using ultrasound‐guided fine needle aspiration cytology , 2013, Cytopathology : official journal of the British Society for Clinical Cytology.

[13]  H. Dralle,et al.  Prognostic Impact of N Staging in 715 Medullary Thyroid Cancer Patients: Proposal for a Revised Staging System , 2013, Annals of surgery.

[14]  H. Dralle,et al.  Biological relevance of medullary thyroid microcarcinoma. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  Moon-Kyu Lee,et al.  Clinicopathological Characteristics and Prognostic Factors of Medullary Thyroid Carcinoma , 2010 .

[16]  A. Pinchera,et al.  Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. , 2010, The Journal of clinical endocrinology and metabolism.

[17]  H. Gharib,et al.  Medullary thyroid cancer: management guidelines of the American Thyroid Association. , 2009, Thyroid : official journal of the American Thyroid Association.

[18]  C. Pirich,et al.  Long‐term prognosis of medullary thyroid carcinoma , 2008, Clinical endocrinology.

[19]  A. Toniato,et al.  Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  E. Mirallié,et al.  Central neck dissection in the management of sporadic medullary thyroid microcarcinoma. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  E. Kebebew,et al.  Extent of disease and practice patterns for medullary thyroid cancer. , 2005, Journal of the American College of Surgeons.

[22]  K. Kameyama,et al.  Medullary thyroid carcinoma: nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002. , 2004, Endocrine journal.

[23]  M. Luster,et al.  Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995. , 2004, Thyroid : official journal of the American Thyroid Association.

[24]  R. Görges,et al.  Role of conventional ultrasound and color Doppler sonography in the diagnosis of medullary thyroid carcinoma. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[25]  T. Schilling,et al.  Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. , 2001, Surgery.

[26]  B. Ponder,et al.  Guidelines for diagnosis and therapy of MEN type 1 and type 2. , 2001, The Journal of clinical endocrinology and metabolism.

[27]  John P. Bilezikian,et al.  CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 , 2001 .

[28]  O. Haas,et al.  Sporadic Versus Familial Medullary Thyroid Microcarcinoma: A Histopathologic Study of 50 Consecutive Patients , 2001, The American journal of surgical pathology.

[29]  Q. Duh,et al.  Medullary thyroid carcinoma , 2000, Cancer.

[30]  H. Heshmati,et al.  Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). , 2000, The Journal of clinical endocrinology and metabolism.

[31]  M. Schlumberger,et al.  Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients , 1998 .

[32]  C. Key,et al.  Prognostic factors for thyroid carcinoma , 1997, Cancer.

[33]  L. Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.